Chief Accounting Officer
Canopy Growth Corp (CGC)Equibles does not estimate personal net worth.
Get an email with a short summary when Canopy Growth Corp publishes a filing, an earnings call transcript or a press release.
Get CGC alertsThomas Stewart is recorded as CFO and Chief Accounting Officer at Canopy Growth Corp (CGC). The newest filing on record that lists Thomas Stewart as CFO at Canopy Growth Corp (CGC) is dated August 7, 2026. The newest filing on record that lists Thomas Stewart as Chief Accounting Officer at Canopy Growth Corp (CGC) is dated August 7, 2020. Canopy Growth Corp reported in an 8-K filed September 17, 2025 that Thomas Stewart was appointed Chief Accounting Officer, effective September 17, 2025. Canopy Growth Corp reported in an 8-K filed September 17, 2025 that Thomas Stewart was appointed Chief Financial Officer, effective September 17, 2025. Canopy Growth Corp reported in an 8-K filed July 9, 2025 that Thomas Stewart was appointed Interim Chief Financial Officer, effective July 9, 2025. Thomas Stewart has spoken on 2 earnings calls across 1 company, most recently for Canopy Growth Corp on June 15, 2026. Canopy Growth Corp is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Canopy Growth Corp includes Luc Mongeau (CEO and Board Member), Judy A (Chairman), Judy Hong (CFO and Chief Accounting Officer) and 7 others.
“On September 17, 2025, the board of directors (the “Board”) of Canopy Growth Corporation (the “Company”) appointed Thomas Stewart, who had been serving as the Company’s Chief Financial Officer on an interim basis since July 9, 2025, as the Company’s permanent Chief Financial Officer and Chief Accounting Officer (the “Appointment”).”
“On September 17, 2025, the board of directors (the “Board”) of Canopy Growth Corporation (the “Company”) appointed Thomas Stewart, who had been serving as the Company’s Chief Financial Officer on an interim basis since July 9, 2025, as the Company’s permanent Chief Financial Officer and Chief Accounting Officer (the “Appointment”).”
“We reported $71.2 million of net revenue in the fourth quarter of fiscal 2026, which was 10% higher than Q4 of the previous year. Growth in the quarter was driven by the cannabis segment, and in particular, Canada Medical and International Cannabis.”
“I am proud of our disciplined execution, including stronger financial performance, rigorous cost-saving initiatives, a significantly deleveraged balance sheet, and sustained cash flow improvements.”
Start not stated–present
Last confirmed August 7, 2026
Start not stated–present
Last confirmed August 7, 2020
Drug Manufacturers - Specialty & Generic · Healthcare
CFO, Chief Accounting Officer
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Canopy Growth Corp (CGC) | — | — | — |
| 2018 | Canopy Growth Corp (CGC) | — | — | — |
